Alessandra Fabi: Real-Life Analysis of T-DXd in Brain Metastases
Alessandra Fabi, Head of the UOSD of Precision Medicine in Senology. shared the following on LinkedIn:
“An Italian multicenter study on the efficacy of Trastuzumab Deruxtecan (T-DXd) on brain metastases from HER2+ breast cancer. The first real-life data that documents and confirms the importance of T-DXd at the intracranial level. Thanks to all the Italian researchers who contributed to this research!”
Real life outcome analysis of breast cancer brain metastases treated with Trastuzumab Deruxtecan
Authors: Alessandra Fabi, Alessandro Rossi, Roberta Caputo, Simona Pisegna, Simone Scagnoli, Francesco Pantano, Giuliana D’Auria, Palma Fedele, Agnese Fabbri, Claudio Vernieri, Michela Palleschi, Luisa Carbognin, Gianluigi Ferretti, Elena Di Monte, Ida Paris, Francesco Pavese, Ornella Garrone, Antonio Franco, Michelino De Laurentiis, Gianluca Franceschini, Giovanni Scambia, Diana Giannarelli, Riccardo Masetti & Andrea Botticelli
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023